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Protocol
AbstrACt
Introduction Rheumatic heart disease (RHD) is a 
preventable and treatable chronic condition which 
persists in many developing countries largely affecting 
impoverished populations. Handheld echocardiography 
presents an opportunity to address the need for more 
cost-effective methods of diagnosing RHD in developing 
countries, where the disease continues to carry high 
rates of morbidity and mortality. Preliminary studies 
have demonstrated moderate sensitivity as well as 
high specificity and diagnostic odds for detecting RHD 
in asymptomatic patients. We describe a protocol for 
a systematic review on the diagnostic performance 
of handheld echocardiography compared to standard 
echocardiography using the 2012 World Heart Federation 
criteria for diagnosing subclinical RHD.
Methods and analysis Electronic databases including 
PubMed, Scopus, Web of Science and EBSCOhost as well 
as reference lists and citations of relevant articles will be 
searched from 2012 to date using a predefined strategy 
incorporating a combination of Medical Subject Heading 
terms and keywords. The methodological validity and 
quality of studies deemed eligible for inclusion will be 
assessed against review specific Quality Assessment of 
Diagnostic Accuracy Studies 2 criteria and information 
on metrics of diagnostic accuracy and demographics 
extracted. Forest plots of sensitivity and specificity as well 
as scatter plots in receiver operating characteristic (ROC) 
space will be used to investigate heterogeneity. If possible, 
a meta-analysis will be conducted to produce summary 
results of sensitivity and specificity using the Hierarchical 
Summary ROC method. In addition, a sensitivity analysis 
will be conducted to investigate the effect of studies with a 
high risk of bias.
Ethics and dissemination Ethics approval is not 
required for this systematic review of previously published 
literature. The planned review will provide a summary of 
the diagnostic accuracy of handheld echocardiography. 
Results may feed into evidence-based guidelines and 
should the findings of this review warrant a change in 
clinical practice, a summary report will be disseminated 
among leading clinicians and healthcare professionals in 
the field.
PrOsPErO registration number CRD42016051261.
IntrOduCtIOn 
background
Rheumatic heart disease (RHD) is a perma-
nent heart valve condition resulting from an 
abnormal immune reaction to group A strep-
tococcal infection typically occurring in child-
hood.1 If left untreated, disease progression 
can result in irreversible heart valve damage, 
cardiac failure, stroke and premature death.2 3 
Significantly, RHD is a preventable and treat-
able chronic condition which mostly affects 
disadvantaged populations across the world.2 
Even though the disease has mostly been erad-
icated in North America and Europe, barring 
a few indigent pockets, it remains prolific in 
areas of the Middle East, the South Pacific, 
Africa as well as Central and South Asia.2 
The continued persistence of RHD contrib-
utes to considerable amounts of preventable 
morbidity and mortality, particularly among 
adolescents and young adults.4 This adds 
additional strain to what are often already 
overburdened health systems with endemic 
strengths and limitations of this study
 ► We will evaluate the accuracy of handheld
echocardiography for detecting subclinical
rheumatic heart disease in endemic areas, making
the proposed review relevant to current global
agendas.
 ► We will not impose a search filter or any limits in
terms of language during the literature search so as
to minimise the chance of missing studies.
 ► Data extraction will be performed by two independent 
reviewers, thereby reducing the risk of bias.
 ► Accuracy measures (sensitivity and specificity) may
be influenced by underestimated burden of disease
estimates (incidence and prevalence) due to the
scarcity of good quality epidemiological data.
 ► Variation in diagnostic criteria for handheld
echocardiography may affect data synthesis.
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regions, which are typically poorly resourced, bearing the 
brunt of the disease.1 5 Furthermore, the accurate detection 
of subclinical RHD in children and adolescents remains 
hampered by the cost of diagnostic machinery and scarcity of 
trained personnel.6 Alternative RHD screening tests, which 
are both accurate and affordable, are therefore needed in 
many endemic areas. The value of such a screening test is 
that significantly more cases of subclinical RHD might be 
detected, thereby reducing the time to commencement of 
secondary prophylaxis and thus, in turn, improving long-
term outcomes.7
Recently, handheld echocardiography has become widely 
available with a variety of clinical uses.8 Similarly, diagnostic 
accuracy has already been demonstrated in a number 
of studies assessing its value as a screening tool, despite 
some limitations such as lack of Doppler capabilities. Due 
to the non-invasive, safe, portable and relatively inexpen-
sive nature of handheld echocardiography, the device has 
been presented in recent publications as a promising alter-
native to standard echocardiography in resource-limited 
and remote settings.4 8 To test this assertion, the diagnostic 
accuracy of handheld echocardiography needs to be eval-
uated using a systematic approach. This review, therefore, 
proposes to evaluate the accuracy of handheld echocardi-
ography for the detection of RHD in children and adoles-
cents within a screening setting. We seek to generate new 
quantitative evidence for clinicians and guideline devel-
opers to establish evidence-based guidelines for diagnosing 
RHD with handheld echocardiography. Ultimately, this will 
improve the management of patients with RHD, as effective 
treatment of subclinical RHD requires accurate and timely 
diagnosis.
Primary objective
To determine the diagnostic accuracy of handheld echo-
cardiography compared with standard echocardiography 
(two-dimensional (2D), continuous-wave and colour-Dop-
pler echocardiography) performed by an experienced 
imager in conjunction with the 2012 World Heart Federa-
tion (WHF) criteria for the detection of any RHD in chil-
dren and adolescents.
secondary objective
To investigate potential sources of variation in relation to 
age, gender, geographical location, echocardiographic 
criteria and echocardiographer expertise in detecting 
subclinical RHD with handheld echocardiography.
MEthOds And AnAlysIs
The protocol was prepared according to the Preferred 
Reporting Items for Systematic Review and Meta-Anal-
ysis (PRISMA) guidelines. A PRISMA Protocol check-
list is completed and included in online supplementary 
appendix 1.9
Inclusion and exclusion criteria
We will include all primary observational studies 
which compare the diagnostic accuracy of handheld 
Table 1 Search strategy 
Database Search terms Limits
PubMed ((((((((((((((((Hand-held) OR handheld) OR hand held) OR hand-carried) OR hand carried) 
OR HAND) OR HCU) OR HHCU) OR pocket size) OR pocket sized) OR portable) OR 
miniaturisation) OR miniaturised) OR focused) OR focus)) AND ((((‘Echocardiography’[Mesh]) OR 
echocardiography) OR echocardiographic) OR cardiac ultrasound)) AND (((‘Rheumatic Heart 
Disease’[Mesh]) OR rheumatic heart disease) OR RHD)
MeSH terms will be exploded during the search
Limited to 
2012–2017
Scopus 1. Hand-held OR handheld OR hand held OR hand-carried OR hand carried OR HAND OR
HCU OR HHCU OR pocket size* OR portable OR miniatur* OR focus*
2. Echocardiograph* OR cardiac ultrasound
3. Rheumatic Heart Disease OR RHD
#1 AND #2 AND #3
Limited to 
2012–2017
ISI Web of 
Science
1. Hand-held OR handheld OR hand held OR hand-carried OR hand carried OR HAND OR
HCU OR HHCU OR pocket size OR pocket sized OR portable OR Miniaturisation OR
Miniaturised OR focused OR focus
2. Echocardiography OR Echocardiographic OR cardiac ultrasound
3. Rheumatic Heart Disease OR RHD
Combine #1 AND #2 AND #3
Limited to 
2012–2017 
and filtering 
out Medline
EBSCOHost  ► S1. Hand-held OR handheld OR hand held OR hand-carried OR hand carried OR HAND 
OR HCU OR HHCU OR pocket size OR pocket sized OR portable OR Miniaturisation OR 
Miniaturised OR focused OR focus
► S2. Echocardiography OR Echocardiographic OR cardiac ultrasound
► S3. Rheumatic Heart Disease OR RHD
S1 AND S2 AND S3
Limited to 
2012–2017
EBSCO, Elton B Stephens Company; HAND, handheld cardiac ultrasound; HCU, handheld cardiac ultrasound; HHCU, hand-held cardiac 
ultrasound; ISI, Institute for Scientific Information; MeSH, Medical Subject Heading terms; RHD, rheumatic heart disease. 
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echocardiography to the reference standard; standard 
echocardiography performed by an experienced imager 
and in conjunction with the 2012 WHF criteria. Eligible 
studies can be of a cross-sectional, cohort or diagnostic 
case–control design, provided both cases and controls 
have been sampled from the same population. Studies 
which report on, or contain the data necessary to extract 
information on the proportions of true positives (TP), 
false positives (FP), true negatives (TN) and false nega-
tives (FN) will be included. Studies which enrolled only 
those with a confirmed RHD diagnosis will be excluded 
on account of the potential for overestimation of sensi-
tivity. Descriptive studies such as case studies/series will 
also be excluded from this review. Studies in which we are 
unable to generate two-by-two tables, as well as different 
studies which report on duplicate data will not be consid-
ered for inclusion in this review.
We will consider all studies in which samples of study 
participants are either, a randomly, or consecutively 
selected series of individuals from populations in which 
RHD is prevalent worldwide for inclusion. For the 
purposes of this review, children and adolescents will be 
defined as being between the ages of 5 and 17 years (age 
range: ≥5 years to <18 years). More specifically, partici-
pants will be considered children if they are between 5 
and 9 years of age and adolescents if they are between 10 
and 17 years of age.
We will include studies evaluating the accuracy of hand-
held echocardiography for RHD detection. There will 
be no restrictions regarding the type of handheld device 
used or the aptitude of person performing the cardiac 
ultrasound; however, these data will be recorded and 
analysed accordingly. Studies will be deemed eligible 
for inclusion if the reference standard constituted the 
Table 2 Design-specific criteria to assess methodological quality
Categories
Domains
1. Patient selection 2. IT 3. RS 4. Flow and timing
Description Briefly describe the methods of 
patient selection:
Describe the IT (HAND), 
how it was conducted 
and interpreted:
Describe the RS 
(STAND) how it was 
conducted and 
interpreted:
Describe patients that did 
not receive HAND, and/
or STAND or who were 
excluded from the 2×2 
table.
Describe the time interval 
and any interventions 
between the HAND and 
STAND.
Indicator 
questions
(yes, no, 
unclear)
Was a consecutive or random 
sample of patients enrolled?
Were the HAND results 
interpreted without 
knowledge of the results 
of STAND?
Was STAND likely to 
correctly classify the 
target condition?
Was there an appropriate 
time interval between 
HAND and STAND?
Was a case–control design 
avoided?
Was a prespecified 
threshold used?
Were the STAND 
results interpreted 
without knowledge of 
the HAND results?
Did all patients receive 
STAND and was it the 
same RS?
Did the study avoid inappropriate 
exclusions?
Were all patients included 
in the analysis?
*Risk of bias
(low, high,
unclear)
Based on the indicator questions, 
could the selection of patients 
have introduced bias?
Based on the indicator 
questions, could the 
conduct or interpretation 
of HAND have 
introduced bias?
Based on the indicator 
questions, could 
STAND, its conduct or 
its interpretation have 
introduced bias?
Based on the indicator 
questions, could the 
patient flow and timing 
have introduced bias?
Concerns 
Regarding 
Applicability
(low, high, 
unclear)
Describe included patients (prior 
testing, presentation, intended use 
of HAND and setting):
Based on the description of 
included patients, are there 
concerns that the included patients 
do not match the review question?
Are there concerns that 
HAND, its conduct, or 
interpretation differ from 
the review question?
Are there concerns 
that the target 
condition as defined 
by STAND does not 
match the review 
question?
*Criteria for grading risk of bias: If all indicator questions for a single domain are answered ‘ yes’, then the risk of bias will be judged as being
‘ low’;  if any indicator question is answered ‘ no’, then the potential for bias will be flagged and the review authors will be required to judge
the risk of bias with the assistance of the senior author (MEE);  if all or most indicator questions were answered ‘ no’, then the risk of bias
will be judged as being ‘ high’ and  indicator questions are can only be answered as ‘unclear’ when the data are insufficient to allow for the
formulation of a judgement.
Adapted from Whiting et al.11
IT, index test; RS, reference standard. 
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interpretation of echocardiographic findings using the 
2012 WHF criteria when echocardiographic assessment 
by 2D, continuous-wave and colour-Doppler echocardiog-
raphy was performed by a cardiologist or cardiac sonog-
rapher. We will exclude all studies published before 2012 
to omit any study which does not use standard echocar-
diography in conjunction with the 2012 WHF criteria as 
the reference standard. We will consider all studies which 
evaluate any RHD (definite and borderline) as the condi-
tion of interest for inclusion in this review. All case defini-
tions will be consistent with the 2012 WHF criteria.10
search strategy
A comprehensive electronic literature search of 
PubMed, Scopus, Web of Science and EBSCOhost will be 
conducted to identify relevant literature. No restrictions 
in terms of language will be applied during the search. 
Searches will however be limited to only include articles 
published from 2012 up until the present. All sources will 
be systematically searched using a combination, where 
relevant, of both free text words and Medical Subject 
Heading terms. Search strategies will be tailored to meet 
the requirements of each electronic database as in table 1 
below. Search terms will include synonyms for ‘rheumatic 
heart disease’, ‘echocardiography’ and ‘handheld’. A list 
of all articles identified through the literature search will 
be compiled and references managed using Mendeley 
software. In addition, a manual search of all eligible arti-
cles’ reference lists, articles citing eligible articles as well 
as relevant review articles will be carried out to identify 
any additional literature not identified by the compre-
hensive electronic literature search. Abstracts from any 
relevant conference proceedings will also be searched for 
among appropriate websites and followed up on if eligi-
bility requirements are sufficiently met. Finally, experts 
in the field will be contacted for additional information 
where necessary.
selection of studies for inclusion
The titles and/or abstracts of all articles identified by the 
literature search will be screened independently by two 
reviewers. Based on the predefined inclusion and exclu-
sion criteria any clearly ineligible studies will be excluded. 
Following this, the full-text versions of all potentially 
eligible studies will then be reviewed by two indepen-
dent reviewers to assess their eligibility. Any discrepancies 
regarding eligibility will be resolved through discussion 
and consensus with a third reviewer.
data extraction and management
Using a predefined data extraction form, two reviewers 
will independently extract the following information 
from all studies meeting the criteria for inclusion:
► Study identifiers: author(s), year of publication,
journal;
► Study characteristics: study design, study country/
setting/context, study population/participants,
sample size, participant recruitment procedures,
participant demographics and RHD prevalence 
(pretest probability);
► Reference standard and index test details:
 – General: test positive or negative;
 – Specific: individual findings on cardiac ultrasound;
 – Expertise of person(s) performing and/or inter-
preting tests: expert versus non-expert;
 – Diagnostic criteria: test threshold(s);
 – Number of missing or unavailable test results.
► Diagnostic test outcome measures: sensitivity, speci-
ficity, positive and negative predictive values, number
of TP, FP, TN and FN.
If necessary, any disagreements will be resolved through 
discussion with a third reviewer until a consensus is 
reached. Any data missing from the reports of included 
studies will be requested from study authors. In cases 
where studies have used different diagnostic criteria for 
handheld echocardiography, attempts will be made to 
standardise them to mirror the 2012 WHF criteria as 
closely as possible. The information garnered through 
the data extraction process will be used to determine 
each study’s quality as well as for synthesising evidence.
risk of bias and quality assessment
The Quality Assessment of Diagnostic Accuracy Studies 
(QUADAS-2) tool (see table 2) will be used to assess the 
risk of bias and concerns regarding applicability of all 
included studies.11 The tool encompasses four domains 
which have been tailored to meet the specific require-
ments of the review. Two reviewers will independently 
assess the risk of bias in all included studies according 
to the revised QUADAS-2 criteria. Any discrepancies will 
be resolved through discussion until consensus is reached 
and with the assistance of a third reviewer if necessary. 
Both text and graphics will be used to demonstrate the 
results.
subgroup and sensitivity analyses
Subgroup analysis may be performed, considering 
specific characteristics of the studies, such as echocardi-
ography protocol, training background of the examiner, 
age and geographical location.
We will conduct a sensitivity analysis to investigate the 
effect of variations in criteria on the overall accuracy 
of diagnosis. In addition, we will explore the effect of 
excluding studies with a high risk of bias on the accuracy 
of summary estimates, sensitivity and specificity. We will 
not investigate publication bias.
statistical analysis and data synthesis
We will first analyse data descriptively by plotting the 
sensitivity and specificity (including 95% CIs) of all 
included studies in both forest plots and receiver oper-
ating characteristic (ROC) space. These plots will be 
generated using the Review Manager software package.12 
If there are sufficient data, we will conduct a meta-analysis 
to produce summary results of sensitivity and specificity. 
Because we anticipate that studies will have different 
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positivity thresholds due to the use of different sets of 
diagnostic criteria, we will pool the results using the 
hierarchical summary receiver operating characteristic 
(HSROC) method. Meta-analysis will be performed using 
SAS V.9.4/STATA V.14.2 software.13 We will also explore, 
through metaregression, the relationship of test accu-
racy with categorical or continuous covariates such as test 
threshold.14
Investigations of heterogeneity will initially begin by 
visually examining the forest and ROC plots for hetero-
geneity in sensitivity and specificity. We will then analyse 
the possible sources of heterogeneity as covariates in the 
statistical models. Potential sources of heterogeneity to be 
investigated as categorical variables include; age (children 
vs adolescents), sex (male vs female), geographical loca-
tion (high vs low/middle-income countries), diagnostic 
criteria (single vs multiple views and different thresholds) 
and echocardiographer expertise (expert vs non-expert).
Presenting and reporting of results
The study selection process will be summarised in the 
form of a flow diagram detailing the reasoning behind 
all exclusions. Results will be reported in accordance with 
the PRISMA guidelines.15
dissemination
The planned review will provide a summary of the diag-
nostic accuracy of handheld echocardiography. Results 
may feed into evidence-based guidelines and will there-
fore be disseminated to members of the WHF criteria 
working group. Should the findings of this review warrant 
a change in clinical practice, a summary report will be 
circulated among leading clinicians and healthcare 
professionals in the field.
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